These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17562440)

  • 1. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.
    Larsen A; Bjørge B; Klementsen B; Helgeland L; Wentzel-Larsen T; Fagerhol MK; Hovdenak N; Dahl O
    Acta Oncol; 2007; 46(5):639-50. PubMed ID: 17562440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers.
    Larsen A; Hovdenak N; Karlsdottir A; Wentzel-Larsen T; Dahl O; Fagerhol MK
    Scand J Gastroenterol; 2004 Nov; 39(11):1113-8. PubMed ID: 15545170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study.
    Hille A; Rave-Fränk M; Christiansen H; Herrmann MK; Kertesz T; Hermann RM; Wolff HA; Schirmer M; Hess CF; Ramadori G
    Scand J Gastroenterol; 2009; 44(8):939-46. PubMed ID: 19504404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
    Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment.
    Hille A; Schmidt-Giese E; Hermann RM; Herrmann MK; Rave-Fränk M; Schirmer M; Christiansen H; Hess CF; Ramadori G
    Scand J Gastroenterol; 2008 Jan; 43(1):52-8. PubMed ID: 18938774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?
    Wedlake L; McGough C; Hackett C; Thomas K; Blake P; Harrington K; Tait D; Khoo V; Dearnaley D; Andreyev HJ
    Aliment Pharmacol Ther; 2008 May; 27(10):980-7. PubMed ID: 18315578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy.
    Varela E; Antolín M; Guarner F; Verges R; Giralt J; Malagelada JR
    Aliment Pharmacol Ther; 2009 Jul; 30(2):175-85. PubMed ID: 19392859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
    Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
    Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer.
    Hille A; Schmidberger H; Hermann RM; Christiansen H; Saile B; Pradier O; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1488-93. PubMed ID: 16137837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
    Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage.
    Heemsbergen WD; Peeters ST; Koper PC; Hoogeman MS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):3-10. PubMed ID: 16814954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer.
    Sanguineti G; Endres EJ; Parker BC; Bicquart C; Little M; Chen G; Berilgen J
    Acta Oncol; 2008; 47(2):301-10. PubMed ID: 18210303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Education and imaging. Gastrointestinal: radiation proctitis.
    Venerito M; Mönkemüller K; Rickes S; Malfertheiner P
    J Gastroenterol Hepatol; 2007 May; 22(5):761. PubMed ID: 17444871
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic gastrointestinal toxicity after external-beam radiation therapy for prostate cancer].
    Sefrová J; Paluska P; Odrázka K; Jirkovský V
    Klin Onkol; 2009; 22(5):233-41. PubMed ID: 19886362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
    Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of radiation proctitis with hyperbaric oxygen.
    Jones K; Evans AW; Bristow RG; Levin W
    Radiother Oncol; 2006 Jan; 78(1):91-4. PubMed ID: 16337705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proctitis after conventional external radiation therapy for prostate cancer: importance of minimizing posterior rectal dose.
    Cho KH; Lee CK; Levitt SH
    Radiology; 1995 Jun; 195(3):699-703. PubMed ID: 7753997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.